Clinical Trial Update: A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a nutritional supplement for pancreatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Alberta | Conditions: Pancreatic Cancer | Phase 2 | Status: WITHDRAWN